References

Abbas, R., and J.W. Fisher. 1997. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 147(1):15-30.

Abbas, R.R., C.S. Seckel, J.K. Kidney, and J.W. Fisher. 1996. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos. 24(12):1340-1346.

ACS (American Cancer Society). 2006. Statistics 2006. American Cancer Society [online]. Available: http://www.cancer.org/docroot/stt/stt_0.asp [accessed June 21, 2006].

Adgate, J.L., L.E. Eberly, C. Stroebel, E.D. Pellizzari, and K. Sexton. 2004. Personal, indoor, and outdoor VOC exposures in a probability sample of children. J. Expo. Anal. Environ. Epidemiol. 14(Suppl. 1):S4-S13.

Albanese, R.A., H.T. Banks, M.V. Evans, and L.K. Potter. 2002. Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue. Bull. Math. Biol. 64(1):97-131.

Alefeld, G., and J. Herzberger. 1983. Introduction to Interval Computations. New York: Academic Press.

Allen, B.C., and J.W. Fisher. 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13(1):71-86.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509.

Altuntas, T.G., R.A. Zager, and E.D. Kharasch. 2003. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in a human proximal tubular cell line. Toxicol. Appl. Pharmacol. 193(1): 55-65.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues References Abbas, R., and J.W. Fisher. 1997. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 147(1):15-30. Abbas, R.R., C.S. Seckel, J.K. Kidney, and J.W. Fisher. 1996. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos. 24(12):1340-1346. ACS (American Cancer Society). 2006. Statistics 2006. American Cancer Society [online]. Available: http://www.cancer.org/docroot/stt/stt_0.asp [accessed June 21, 2006]. Adgate, J.L., L.E. Eberly, C. Stroebel, E.D. Pellizzari, and K. Sexton. 2004. Personal, indoor, and outdoor VOC exposures in a probability sample of children. J. Expo. Anal. Environ. Epidemiol. 14(Suppl. 1):S4-S13. Albanese, R.A., H.T. Banks, M.V. Evans, and L.K. Potter. 2002. Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue. Bull. Math. Biol. 64(1):97-131. Alefeld, G., and J. Herzberger. 1983. Introduction to Interval Computations. New York: Academic Press. Allen, B.C., and J.W. Fisher. 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13(1):71-86. Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495. Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509. Altuntas, T.G., R.A. Zager, and E.D. Kharasch. 2003. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in a human proximal tubular cell line. Toxicol. Appl. Pharmacol. 193(1): 55-65.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Altuntas, T.G., B.S. Park, and E.D. Kharasch. 2004. Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A). Chem. Res. Toxicol. 17(3):435-445. Anand, S.S., M.M. Mumtaz, and H.M. Mehendale. 2005a. Dose-dependent liver tissue repair after chloroform plus trichloroethylene binary mixture. Basic Clin. Pharmacol. Toxicol. 96(6):436-444. Anand, S.S., M.M. Mumtaz, and H.M. Mehendale. 2005b. Dose-dependent liver regeneration in chloroform, trichloroethylene and allyl alcohol ternary mixture hepatotoxicity in rats. Arch. Toxicol. 79(11):671-682. Andelman, J.B., S.M. Meyers, and L.C. Wilder. 1986. Volatilization of organic chemicals from indoor uses of water. Pp. 323-330 in Chemicals in the Environment, J.N. Lester, R. Perry, and R.M. Sterritt, eds. London: Selper Ltd. Anders, M.W., A.A. Elfarra, and L.H. Lash. 1987. Cellular effects of reactive intermediates: Nephrotoxicity of S-conjugates of amino acids. Arch. Toxicol. 60(1-3):103-108. Andersen, M.E., J.J. Mills, and R.L. Jirtle. 1995. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102(1-2):223-237. Anna, C.H., R.R. Maronpot, M.A. Pereira, J.F. Foley, D.E. Malarkey, and M.W. Anderson. 1994. ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15(10):2255-2261. Anttila, A., E. Pukkala, M. Sallmen, S. Hernberg, and K. Hemminki. 1995. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J. Occup. Environ. Med. 37(7):797-806. Aranyi, C., W.J. O’Shea, J.A. Graham, and F.J. Miller. 1986. The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam. Appl. Toxicol. 6(4):713-720. Arito, H., M. Takahashi, H. Tsuruta, and T. Ishikawa. 1994. Age-related changes in electrocardiographic responses to trichloroethylene inhalation in conscious rats. Ind. Health 32(3):129-144. Arms, A.D., and C.C. Travis. 1988. Reference Physiological Parameters in Pharmacokinetic Modeling. EPA/600/6-88/004. Office of Health and Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC. July 1988. Armstrong, B.G. 1990. The effects of measurement errors on relative risk regressions. Am. J. Epidemiol. 132(6):1176-1184. Asal, N.R., J.R. Geyer, D.R. Risser, E.T. Lee, S. Kadamani, and N. Cherng. 1988. Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect. Prev. 13(3-4):263-279. Aschengrau, A., D. Ozonoff, C. Paulu, P. Coogan, R. Vezina, T. Heeren, and V. Zhang. 1993. Cancer risk and tetrachloroethylene-contaminated drinking water in Massachusetts. Arch. Environ. Health. 48(5):284-292. Astrand, I. 1975. Uptake of solvents in the blood and tissues of man [review]. Scand. J. Work Environ. Health 1(4):199-218. ATSDR (Agency for Toxic Substances and Disease Registry). 1990. Toxicological Profile for cis-, trans-1,2-Dichloroethene (Update Draft). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA. ATSDR (Agency for Toxic Substances and Disease Registry). 1995. Toxicological Profile for 1,1,1-Trichloroethane (Update). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA. ATSDR (Agency for Toxic Substances and Disease Registry). 1996. Toxicological Profile for 1,2-Dichloroethene. U.S. Department of Health and Human Services, Public Health Ser-

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues vice, Agency for Toxic Substances and Disease Registry, Atlanta, GA. [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp87.html [accessed May 9, 2006]. ATSDR (Agency for Toxic Substances and Disease Registry). 1997a. Toxicological Profile for Trichloroethylene (Update). U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp19.html [accessed March 2, 2006]. ATSDR (Agency for Toxic Substances and Disease Registry). 1997b. Toxicological Profile for Tetrachloroethylene. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA [online]. Available: http://www.atsdr.cdc.gov/toxprofiles/tp18.html [accessed May 9, 2006]. ATSDR (Agency for Toxic Substances and Disease Regristry). 1998. Volatile Organic Compounds in Drinking Water and Adverse Pregnancy Outcomes: United States Marine Corps Base, Camp Lejeune, North Carolina. Agency for Toxic Substances and Disease Registry, Atlanta, GA. August 1998 [online]. Available: http://www.atsdr.cdc.gov/HS/lejeune/ [accessed March 15, 2006]. ATSDR (Agency for Toxic Substances and Disease Regristry). 2003. Progress Report: Survey of Specific Childhood Cancers and Birth Defects Among Children Whose Mothers Were Pregnant While Living at U.S. Marine Corps Base Camp Lejeune, North Carolina, 1968-1985. Agency for Toxic Substances and Disease Registry, Atlanta, GA. July 2003 [online]. Available: http://www.atsdr.cdc.gov/sites/lejeune/lejeunehealthsurvey.pdf [accessed May 15, 2006]. Aupérin, A., S. Benhamou, C. Ory-Paoletti, and R. Flamant. 1994. Occupational risk factors for renal cell carcinoma: A case-control study. Occup. Environ. Med. 51(6):426-428. Axelson, O., K. Andersson, C. Hogstedt, B. Holmberg, G. Molina, and A. de Verdier. 1978. A cohort study on trichloroethylene exposure and cancer mortality. J. Occup. Med. 20(3):194-196. Axelson, O., A. Selden, K. Andersson, and C. Hogstedt. 1994. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J. Occup. Med. 36(5):556-562. Backe, B. 1993. Maternal smoking and age. Effect on birthweight and risk for small-for-gestational age births. Acta Obstet. Gynecol. Scand. 72(3):172-176. Bai, C.L., and N.H. Stacey. 1993. Mechanism of trichloroethylene-induced elevation of individual serum bile acids. II. In vitro and in vivo interference by trichloroethylene with bile acid transport in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 121(2):296-302. Bailer, A.J., L.T. Stayner, R.J. Smith, E.D. Kuempel, and M.M. Prince. 1997. Estimating benchmark concentrations and other non-cancer endpoints in epidemiology studies. Risk Anal. 17(6):771-780. Baillargeon, J. 2001. Characteristics of the healthy worker effect. Occup. Med. 16(2): 359-366. Baraona, E., L. Shoichet, K. Navder, and C.S. Lieber. 2002a. Mediation by nitric oxide of the stimulatory effects of ethanol on blood flow. Life Sci. 70(25):2987-2995. Baraona, E., G.A. Zeballos, L. Shoichet, K.M. Mak, and C.S. Lieber. 2002b. Ethanol consumption increases nitric oxide production in rats, and its peroxynitrite-mediated toxicity is attenuated by polyenylphosphatidylcholine. Alcohol Clin. Exp. Res. 26(6):883-889. Bardodej, Z., and J. Vyskocil. 1956. The problem of trichloroethylene in occupational medicine: Trichloroethylene metabolism and its effect on the nervous system evaluated as a means of hygienic control. AMA Arch. Ind. Health 13(6):581-592. Barret, L., S. Torch, Y. Usson, B. Gonthier, and R. Saxod. 1991. A morphometric evaluation of the effects of trichloroethylene and dichloroacetylene on the rat mental nerve. Preliminary results. Neurosci. Lett. 131(2):141-144. Barret, L., S. Torch, C.L. Leray, L. Sarlieve, and R. Saxod. 1992. Morphometric and biochemi-

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues cal studies in trigeminal nerve of rat after trichloroethylene or dichlororacetylene oral administration. Neurotoxicology 13(3):601-614. Barrett, D.A., and N. Rutter. 1994. Transdermal delivery and the premature neonate. Crit. Rev. Ther. Drug Carrier Syst. 11(1):1-30. Barshop, B.A., R.K. Naviaux, K.A. McGowan, F. Levine, W.L. Nyhan, A. Loupis-Geller, and R.H. Haas. 2004. Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol. Genet. Metab. 83(1-2):138-149. Bartell, S.M. 2005. Risk assessment. Chapter 32 in Environmental Health: From Local to Global, H. Frumkin, ed. San Francisco, CA: Jossey-Bass. Barton, H.A., C.D. Flemming, and J.C. Lipscomb. 1996. Evaluating human variability in chemical risk assessment: Hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology 111(1-3):271-287. Bartonicek, V., and V. Teisinger. 1962. Effect of tetraethyl thiuram disulphide (disulfiram) on metabolism of trichloroethylene in man. Br. J. Ind. Med. 19:216-221. Beaumont, J.J., and N.E. Breslow. 1981. Power considerations in epidemiologic studies of vinyl chloride workers. Am. J. Epidemiol. 114(5):725-734. Beckett, G.J., A.F. Howie, R. Hume, B. Matharoo, C. Hiley, P. Jones, and R.C. Strange. 1990. Human glutathione S-transferases: Radioimmunoassay studies on the expression of alpha-, mu- and pi-class isoenzymes in developing lung and kidney. Biochim. Biophys. Acta 1036(3):176-182. Beliveau, M., R. Tardif, and K. Krishnan. 2003. Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol. Appl. Pharmacol. 189(3):221-232. Berger, T., and C.M. Horner. 2003. In vivo exposure of female rats to toxicants may affect oocyte quality. Reprod. Toxicol. 17(3):273-281. Berger, T., M.G. Miller, and C.M. Horner. 2000. In vitro fertilization after in vivo treatment of rats with three reproductive toxicants. Reprod. Toxicol. 14(1):45-53. Bernauer, U., G. Birner, W. Dekant, and D. Henschler. 1996. Biotransformation of trichloroethene: Dose dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation. Arch. Toxicol. 70(6):338-346. Bernstine, J.B., A.E. Meyer, and H.B. Hayman. 1954. Maternal and fetal blood estimation following the administration of chloral hydrate during labour. J. Obstet. Gynaecol. Br. Emp. 61(5):683-685. Beroud, C., G. Collod-Beroud, C. Boileau, T. Soussi, and C. Junien. 2000. UMD (Universal mutation database): A generic software to build and analyze locus-specific databases. Hum. Mutat. 15(1):86-94. Birner, G., S. Vamvakas, W. Dekant, and D. Henschler. 1993. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L- cysteine is a urinary metabolite after occupational 1,1, 2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure. Environ. Health Perspect. 99:281-284. Birner, G., M. Werner, M.M. Ott, and W. Dekant. 1995. Sex differences in hexachlorobutadiene biotransformation and nephrotoxicity. Toxicol. Appl. Pharmacol. 132(2):203-212. Birner, G., M. Werner, E. Rosner, C. Mehler, and W. Dekant. 1998. Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine sulfoxide. Chem. Res. Toxicol. 11(7):750-757. Blain, L., P. Lachapelle, and S. Molotchnikoff. 1992. Evoked potentials are modified by long term exposure to trichloroethylene. Neurotoxicology 13(1):203-206. Blair, A., P. Hartge, P.A. Stewart, M. McAdams, and J. Lubin. 1998. Mortality and cancer incidence of aircraft maintenance workers exposed to trichloroethylene and other organic solvents and chemicals: Extended follow up. Occup. Environ. Med. 55(3):161-171.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Bloemen, L.J., and J. Tomenson. 1995. Increased incidence of renal cell tumours in a cohort of cardboard workers exposed to trichloroethylene. Arch. Toxicol. 70(2):129-133. Bloemen, L.J., A.C. Monster, S. Kezic, J.N. Commandeur, H. Veulemans, N.P. Vermeulen, and J.W. Wilmer. 2001. Study on the cytochrome P-450- and glutathione-dependent biotransformation of trichloroethylene in humans. Int. Arch. Occup. Environ. Health 74(2):102-108. Blossom, S.J., N.R. Pumford, and K.M. Gilbert. 2004. Activation and attenuation of apoptosis of CD4+ T cells following in vivo exposure to two common environmental toxicants, trichloroacetaldehyde hydrate and trichloroacetic acid. J. Autoimmun. 23(3):211-220. Board, P.G. 1981. Biochemical genetics of glutathione-S-transferase in man. Am. J. Hum. Genet. 33(1):36-43. Board, P., M. Coggan, P. Johnston, V. Ross, T. Suzuki, and G. Webb. 1990. Genetic heterogeneity of the human glutathione transferases: A complex of gene families. Pharmacol. Ther. 48(3):357-369. Bogen, K.T., B.W. Colston, Jr., and L.K. Machicao. 1992. Dermal absorption of dilute aqueous chloroform, trichloroethylene, and tetra-chloroethylene in hairless guinea pigs. Fundam. Appl. Toxicol. 18(1):30-39. Boice, J.D., and J.K. McLaughlin. 2001. Errors in TCE analysis. Environ. Health Perspect. 109(3):A108-A109. Boice, J.D., Jr., D.E. Marano, J.P. Fryzek, C.J. Sadler, and J.K. McLaughlin. 1999. Mortality among aircraft manufacturing workers. Occup. Environ. Med. 56(9):581-597. Bois, F.Y. 2000a. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 108(Suppl. 2):307-316. Bois, F.Y. 2000b. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ. Health Perspect. 108(Suppl. 2):275-282. Bois, F.Y., and D.R. Maszle. 1997. MCSIM: A simulation program. J. Stat. Software 2(9) [online]. Available: http://www.jstatsoft.org/v02/i09/ [accessed March 28, 2006]. Bolt, H.M., M. Lammert, S. Selinski, and T. Brüning. 2004. Urinary alpha1-microglobulin excretion as biomarker of renal toxicity in trichloroethylene-exposed persons. Int. Arch. Occup. Environ. Health 77(3):186-190. Borak, J., M. Russi, and J.P. Puglisi. 2000. Meta-analysis of TCE carcinogenicity. Environ. Health Perspect. 108(12):A542-A544. Bosgra, S., W. Mennes, and W. Seinen. 2005. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis. Toxicology 206(3):309-323. Bouyer, J., and D. Hemon. 1993. Retrospective evaluation of occupational exposures in population-based case-control studies: General overview with special attention to job exposure matrices. Int. J. Epidemiol. 22(Suppl. 2):S57-S64. Bove, F., Y. Shim, and P. Zeitz. 2002. Drinking water contaminants and adverse pregnancy outcomes: A review. Environ. Health Perspect. 110(Suppl. 1):61-74. Bove, F.J., M.C. Fulcomer, J.B. Klotz, J. Esmart, E.M. Dufficy, and J.E. Savrin. 1995. Public drinking water contamination and birth outcomes. Am. J. Epidemiol. 141(9):850-862. Bovenzi, M., F. Barbone, A. Betta, M. Tommasini, and W. Versini. 1995. Scleroderma and occupational exposure. Scand. J. Work Environ. Health 21(4):289-292. Bovenzi, M., F. Barbone, F.E. Pisa, A. Betta, L. Romeo, A. Tonello, D. Biasi, and P. Caramaschi. 2004. A case-control study of occupational exposures and systemic sclerosis. Int. Arch. Occup. Environ. Health 77(1):10-16. Boyer, A.S., W.T. Finch, and R.B. Runyan. 2000. Trichloroethylene inhibits development of embryonic heart valve precursors in vitro. Toxicol. Sci. 53(1):109-117. Boyes, W.K., P.J. Bushnell, K.M. Crofton, M. Evans, and J.E. Simmons. 2000. Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario. Environ. Health Perspect. 108(Suppl. 2):317-322.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Boyes, W.K., M. Bercegeay, J.S. Ali, T. Krantz, J. McGee, M. Evans, J.H. Raymer, P.J. Bushnell, and J.E. Simmons. 2003. Dose-based duration adjustments for the effects of inhaled trichloroethylene on rat visual function. Toxicol. Sci. 76(1):121-130. Brambilla, G., and A. Martelli. 2004. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology 196(1-2):1-19. Brashear, W.T., C.T. Bishop, and R. Abbas. 1997. Electrospray analysis of biological samples for trace amounts of trichloroacetic acid, dichloroacetic acid, and monochloroacetic acid. J. Anal. Toxicol. 21(5):330-334. Brauch, H., G. Weirich, M.A. Hornauer, S. Storkel, T. Wohl, and T. Bruning. 1999. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl. Cancer Inst. 91(10):854-861. Brauch, H., G. Weirich, B. Klein, S. Rabstein, H.M. Bolt, and T. Bruning. 2004. VHL mutations in renal cell cancer: Does occupational exposure to trichloroethylene make a difference? Toxicol. Lett. 151(1):301-310. Brenner, H., and O. Gefeller. 1993. Use of the positive predictive value to correct for disease misclassification in epidemiologic studies. Am. J. Epidemiol. 138(11):1007-1015. Bringmann, G., R. God, S. Fahr, D. Feineis, K. Fornadi, and F. Fornadi. 1999. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline in human blood after intake of the hypnotic chloral hydrate. Anal. Biochem. 270(1):167-175. Briving, C., I. Jacobson, A. Hamberger, P. Kjellstrand, K.G. Haglid, and L.E. Rosengren. 1986. Chronic effects of perchloroethylene and trichloroethylene on the gerbil brain amino acids and glutathione. Neurotoxicology 7(1):101-108. Bross, G., D. DiFranceisco, and M.E. Desmond. 1983. The effect of low dosages of trichloroethylene on chick development. Toxicology 28(4):283-294. Brown, R.P., M.D. Delp, S.L. Lindstedt, L.B. Rhomberg, and R.P. Beliles. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13(4):407-484. Brüning, T., and H.M. Bolt. 2000. Renal toxicity and carcinogenicity of trichloroethylene: Key results, mechanisms, and controversies. Crit. Rev. Toxicol. 30(3):253-285. Brüning, T., G. Weirich, M.A. Hornauer, H. Hofler, and H. Brauch. 1997a. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch. Toxicol. 71(5):332-335. Brüning, T., M. Lammert, M. Kempkes, R. Thier, K. Golka, and H.M. Bolt. 1997b. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch. Toxicol. 71(9):596-599. Brüning, T., S. Vamvakas, V. Makropoulos, and G. Birner. 1998. Acute intoxication with trichloroethene: Clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. Toxicol. Sci. 41(2):157-165. Brüning, T., H. Mann, H. Melzer, A.G. Sundberg, and H.M. Bolt. 1999a. Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene. Occup. Med. (Lond) 49(5):299-305. Brüning, T., A.G. Sundberg, G. Birner, M. Lammert, H.M. Bolt, E.L. Appelkvist, R. Nilsson, and G. Dallner. 1999b. Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure. Arch. Toxicol. 73(4):246-254. Brüning, T., B. Pesch, B. Wiesenhutter, S. Rabstein, M. Lammert, A. Baumuller, and H.M. Bolt. 2003. Renal cell cancer risk and occupational exposure to trichloroethylene: Results of a consecutive case-control study in Arnsberg, Germany. Am. J. Ind. Med. 43(3):274-285. Brzezinski, M.R., H. Boutelet-Bochan, R.E. Person, A.G. Fantel, and M.R. Juchau. 1999. Catalytic activity and quantitation of cytochrome P-450 2E1 in prenatal human brain. J. Pharmacol. Exp. Ther. 289(3):1648-1653. Buben, J.A., and E.J. O’Flaherty. 1985. Delineation of the role of metabolism in the hepato-

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues toxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol. Appl. Pharmacol. 78(1):105-122. Buckpitt, A., A.M. Chang, A. Weir, L. Van Winke, X. Duan, R. Philpot, and C. Plopper. 1995. Relationship of cytochrome P450 activity to Clara cell toxicity. IV. Metabolism of naphthalene to naphthalene oxide in microdissected airways from mice, rats and hamsters. Mol. Pharmacol. 47(1):74-81. Budowsky, E.I. 1976. The mechanism of the mutagenic action of hydroxylamines. Prog. Nucl. Acid Res. Mol. Biol. 16:125-188. Bull, R.J. 2000. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ. Health Perspect. 108(Suppl. 2):241-259. Bull, R.J., I.M. Sanchez, M.A. Nelson, J.L. Larson, and A.L. Lansing. 1990. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63(3):341-359. Bull, R.J., G.A. Orner, R.S. Cheng, L. Stillwell, A.J. Stauber, L.B. Sasser, M.K. Lingohr, and B.D. Thrall. 2002. Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene. Toxicol. Appl. Pharmacol. 182(1):55-65. Bull, R.J., L.B. Sasser, and X.C. Lei. 2004. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice. Toxicology 199(2-3):169-183. Bunce, N.J., and U.A. Schneider. 1994. Chemical lifetimes of chlorinated aliphatic priority pollutants in the Canadian troposphere. J. Photochem. Photobiol. A 81:93-101. Burmaster, D.E. 1982. The new pollution-groundwater contamination. Environment 24(2):6-36. Bushnell, P.J., and W.M. Oshiro. 2000. Behavioral components of tolerance to repeated inhalation of trichloroethylene (TCE) in rats. Neurotoxicol. Teratol. 22(2):221-229. Butler, M.A., M. Iwasaki, FP. Guengerich, and F.F. Kadlubar. 1989. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86(20):7696-7700. Byers, V.S., A.S. Levin, D.M. Ozonoff, and R.W. Baldwin. 1988. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukemia. Cancer Immunol. Immunother. 27(1):77-81. Byington, K.H., and K.C. Leibman. 1965. Metabolism of trichloroethylene in liver microsomes. II. Identification of the reaction product as chloral hydrate. Mol. Pharmacol. 1(3):247-254. Cai, H., and F.P. Guengerich. 2000. Acylation of protein lysines by trichloroethylene oxide. Chem. Res. Toxicol. 13(5):327-335. Cai, H., and F.P. Guengerich. 2001. Reaction of trichloroethylene and trichloroethylene oxide with cytochrome P450 enzymes: Inactivation and sites of modification. Chem. Res. Toxicol. 14(4):451-458. Cakmak, A., A. Ekici, M. Ekici, M. Arslan, A. Iteginli, E. Kurtipek, and T. Kara. 2004. Respiratory findings in gun factory workers exposed to solvents. Respir. Med. 98(1):52-56. Carlson, G.P. 1974. Enhancement of the hepatotoxicity of trichloroethylene by inducers of drug metabolism. Res. Commun. Chem. Path. Pharmacol. 7(3):637-640. Caro, A.A., and A.I. Cederbaum. 2004. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol. 44:27-42. Carpenter, S.P., J.M. Lasker, and J.L. Raucy. 1996. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol. Pharmacol. 49(2):260-268.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Carter, J.H., H.W. Carter, and A.B. DeAngelo. 1995. Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. Toxicol. Lett. 81(1):55-71. Carter, J.H., H.W. Carter, J.A. Deddens, B.M. Hurst, M.H. George, and A.B. DeAngelo. 2003. A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloroacetic acid. Environ. Health Perspect. 111(1):53-64. Cattley, R.C., R.T. Miller, and J.C. Corton. 1995. Peroxisome proliferators: Potential role of altered hepatocyte growth and differentiation in tumor development. Prog. Clin. Biol. Res. 391:295-303. Cavanagh, J.B., and P.H. Buxton. 1989. Trichloroethylene cranial neuropathy: Is it really a toxic neuropathy or does it activate latent herpes virus? J. Neurol. Neurosururg. Psychiatry 52(3):297-303. Chang, Y.M., C.F. Tai, S.C. Yang, C.J. Chen, T.S. Shih, R.S. Lin, and S.H. Liou. 2003. A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan. Ann. Epidemiol. 13(9):652-660. Chen, H.H., Y.R. Lin, Q.G. Peng, and M.H. Chan. 2005. Effects of trichloroethylene and perchloroethylene on muscle contractile responses and epithelial prostaglandin release and acetylcholinesterase activity in swine trachea. Toxicol. Sci. 83(1):149-154. Chen, Y., J. Cai, M.W. Anders, J.L. Stevens, and D.P. Jones. 2001. Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis. Toxicol. Appl. Pharmacol. 170(3):172-180. Cherrie, J.W., H. Kromhout, and S. Semple. 2001. The importance of reliable exposure estimates in deciding whether trichloroethylene can cause kidney cancer [letter]. J. Cancer Res. Clin. Oncol. 127(6):400-404. Chia, S.E., C.N. Ong., M.F. Tsakok, and A. Ho. 1996. Semen parameters of workers exposured to trichloroethylene. Reprod. Toxicol. 10(4):295-299. Chia, S.E., V.H. Goh, and C.N. Ong. 1997. Endocrine profiles of male workers with exposure to trichloroethylene. Am. J. Ind. Med. 32(2):217-222. Choi, B.C. 1992. Definition, sources, magnitude, effect modifiers, and strategies of reduction of the healthy worker effect. J. Occup. Med. 34(10):979-988. Chow, W.H., G. Gridley, J.K. McLaughlin, J.S. Mandel, S. Wacholder, W.J. Blot, S. Niwa, and J.F. Fraumeni, Jr. 1994. Protein intake and risk of renal cell cancer. J. Nat. Cancer Inst. 86(15):1131-1139. Clewell, H.J., and K.S. Crump. 2005. Quantitative estimates of risk for noncancer endpoints. Risk Anal. 25(2):285-289. Clewell, H.J., III, P.R. Gentry, J.M. Gearhart, B.C. Allen, T.R. Covington, and M.E. Andersen. 1995. Applying Mechanistic Information, Pharmacokinetic Modeling, and Margin of Exposure Evaluations in a Novel Risk Assessment for Trichloroethylene and Its Active Carcinogenic Metabolites: Chloral Hydrate, Trichloroacetic Acid, Dichloroacetic Acid, and Dichlorovinylcysteine. Prepared for OSHA Directorate of Health Standards Programs and U. S. Environmental Protection Agency Office of Health and Environmental Assessment. January 31, 1995. Clewell, H.J., P.R. Gentry, T.R. Covington, and J.M. Gearhart. 2000. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ. Health Perspect. 108(Suppl. 2):283-305. Clewell, R.A., E.A. Merrill, K.O. Yu, D.A. Mahle, T.R. Sterner, D.R. Mattie, P.J. Robinson, J.W. Fisher, and J.M. Gearhart. 2003a. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: A physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Toxicol. Sci. 73(2):235-255. Clewell, R.A., E.A. Merrill, K.O. Yu, D.A. Mahle, T.R. Sterner, J.W. Fisher, and J.M. Gearhart.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues 2003b. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Toxicol. Sci. 74(2):416-436. Coberly, S., D.J. Oudiz, J.W. Overstreet, and L.M. Wiley. 1992. Effects of maternal exposure to trichloroethylene (TCE) on cell proliferation in the mouse preimplantation embryo. Reprod. Toxicol. 6(3):241-245. Cohen, B.L., and G.A. Colditz. 1994. Tests of the linear-no threshold theory for lung cancer induced by exposure to radon. Environ. Res. 64(1):65-89. Cohen, S.M., M.E. Meek, J.E. Klaunig, D.E. Patton, and P.A. Fenner-Crisp. 2003. The human relevance of information on carcinogenic modes of action: Overview. Crit. Rev. Toxicol. 33(6):581-589. Cohn, P., J. Klotz, F. Bove, M. Berkowitz, and J. Fagliano. 1994. Drinking water contamination and the incidence of leukemia and Non-Hodgkin’s lymphoma. Environ. Health Perspect. 102(6-7):556-561. Collier, J.M., O. Selmin, P.D. Johnson, and R.B. Runyan. 2003. Trichloroethylene effects on gene expression during cardiac development. Birth Defects Res. A. Clin. Mol. Teratol. 67(7):488-495. Colt, J.S., and A. Blair. 1998. Partental occupational exposures and risk of childhood cancer. Environ. Health Perspect. 106(Suppl. 3):909-925. Commandeur, J.N., and N.P. Vermeulen. 1990. Identification of N-acetyl(2.2-dichlorovinyl)and N-acetyl(1,2-dichlorovinyl)-L-cysteine as two regioisomeric mercapturic acids of trichloroethylene in the rat. Chem. Res. Toxicol. 3(3):212-218. Committee of Principal Investigators. 1980. WHO cooperative trial on primary prevention of ischaemic heart disease using clofribrate to lower serum cholesterol: Mortality follow-up. Lancet 2(8191):379-385. Committee of Principal Investigators. 1984. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: Final mortality follow-up. Lancet 2(8403):600-604. Cooper, A.J. 2004. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem. Int. 44(8):557-577. Cooper, J.R., and P.J. Friedman. 1958. The enzymic oxidation of chloral hydrate to trichloroacetic acid. Biochem. Pharmacol. 1:76-82. Copeland, K.T., H. Checkoway, A.J. McMichael, and R.H. Holbrook. 1977. Bias due to misclassification in the estimation of relative risk. Am. J. Epidemiol. 105(5):488-495. Corbett, T.H., R.G. Cornell, J.L. Endres, and K. Lieding. 1974. Birth defects among children of nurse-anesthetists. Anesthesiology 41(4):341-344. Cornford, D., L. Csato, D.J. Evans, and M. Opper. 2004. Bayesian analysis of the scatterometer wind retrieval inverse problem: Some new approaches. J. Roy. Stat. Soc. B 66(3):606-626. Corton, J.C., and P.J. Lapinskas. 2005. Peroxisome proliferator-activated receptors: Mediators of phthalate ester-induced effects in the male reproductive tract? Toxicol. Sci. 83(1):4-17. Corton, J.C., S.P. Anderson, and A. Stauber. 2000a. Central role of peroxisome proliferatoractivated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:491-518. Corton, J.C., P.J. Lapinskas, and F.J.Gonzalez. 2000b. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 448(2):139-151. Cory-Slechta, D.A. 1989. Behavioral measures of neurotoxicity. Neurotoxicology 10(2): 271-295.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Cosby, N.C., and W.R. Dukelow. 1992. Toxicology of maternally ingested trichloroethylene (TCE) on embryonal and fetal development in mice and of TCE metabolites on in vitro fertilization. Fundam. Appl. Toxicol. 19(2):268-274. Costa, G., F. Merletti, and N. Segnan. 1989. A mortality cohort study in a north Italian aircraft factory. Br. J. Ind. Med. 46(10):738-743. Coutelle, C., B. Hohn, M. Benesova, C.M. Oneta, P. Quattrochi, H.J. Roth, H. SchmidtGayk, A. Schneeweiss, G. Bastert, and H.K. Seitz. 2004. Risk factors in alcohol associated breast cancer: Alcohol dehydrogenase polymorphism and estrogens. Int. J. Oncol. 25(4):1127-1132. Crofton, K.M., and X. Zhao. 1993. Mid-frequency hearing loss in rats following inhalation exposure to trichloroethylene: Evidence from reflex modification audiometry. Neurotoxicol. Teratol. 15(6):413-423. Crofton, K.M., T.L. Lassiter, and C.S. Rebert. 1994. Solvent-induced ototoxicity in rats: An atypical selective mid-frequency hearing deficit. Hear. Res. 80(1):25-30. Cronk, C.E., M.E. Malloy, A.N. Pelech, R.E. Miller, S.A. Meyer, M. Cowell, and D.G. McCarver. 2003. Completeness of state administrative databases for surveillance of congenital heart disease. Birth Defects Res. A Clin. Mol. Teratol. 67(9):597-603. Crump, K.S. 1984. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4(5):854-871. Crump, K.S., D.G. Hoel, C.H. Langley, and R. Peto. 1976. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36(9 Pt. 1):2973-2979. Cruzan, G., J.R. Cushman, L.S. Andrews, G.C. Granville, R.R. Miller, C.J. Hardy, D.W. Coombs, and P.A. Mullins. 1997. Subchronic inhalation studies of styrene in CD rats and CD-1 mice. Fundam. Appl. Toxicol. 35(2):152-165. Cummings, B.S., and L.H. Lash. 2000. Metabolism and toxicity of trichloroethylene and S(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol. Sci. 53(2):458-466. Cummings, B.S., R.C. Zangar, R.F. Novak, and L.H. Lash. 2000. Cytotoxicity of trichloroethylene and S-(1, 2-dichlorovinyl)-L-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells. Toxicology 150(1-3):83-98. Curry, S.H., P.I. Chu, T.G. Baumgartner, and P.W. Stacpoole. 1985. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin. Pharmacol. Ther. 37(1):89-93. Curry, S.H., A. Lorenz, P.I. Chu, M. Limacher, and P.W. Stacpoole. 1991. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug Dispos. 12(5):375-390. Czirjak, L., and G. Kumanovic. 2002. Exposure to solvents in female patients with scleroderma. Clin. Rheumatol. 21(2):114-118. Dallas, C.E., J.M. Gallo, R. Ramanathan, S. Muralidhara, and J.V. Bruckner. 1991. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. Toxicol. Appl. Pharmacol. 110(2):303-314. Damani, L.A., and A.A. Houdi. 1988. Cytochrome P-450 and FAD-monooxygenase mediated S- and N-oxygenations. Drug Metabol. Drug Interact. 6(3-4):235-244. D’Amico, G., and C. Bazzi. 2003. Urinary protein and enzyme excretion as markers of tubular damage. Curr. Opin. Nephrol. Hypertens. 12(6):639-643. Daniel, F.B., A.B. DeAngelo, J.A. Stober, G.R. Olson, and N.P. Page. 1992. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in male B6C3F1 mouse. Fundam. Appl. Toxicol. 19(2):159-168. Daniel, F.B., J.R. Meier, and A.B. DeAngelo. 1993. Advances in research on carcinogenic and

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues genotoxic by-products of chlorine disinfection: Chlorinated hydroxyfuranones and chlorinated acetic acids. Ann. Ist Super Sanita 29(2):279-291. Daniel, J.W. 1963. The metabolism of 36Cl-labeled trichloroethylene and tetrachloroethylene in the rat. Biochem. Pharmacol. 12:795-802. Darnerud, P.O., A.L. Gustafson, U. Tornwall, and V.J. Feil. 1991. Age- and sex-dependent dichlorovinyl cysteine (DCVC) accumulation and toxicity in the mouse kidney: Relation to development of organic anion transport and beta-lyase activity. Pharmacol. Toxicol. 68(2):104-109. Das, U.G., C.E. Cronk, S.S. Martier, P.M. Simpson, and D.G. McCarver. 2004. Alcohol dehydrogenase 2*3 affects alterations in offspring facial morphology associated with maternal ethanol intake in pregnancy. Alcohol Clin. Exp. Res. 28(10):1598-1606. Davidson, I.W., and R.P. Beliles. 1991. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23(5-6):493-599. Dawson, B.V., P.D. Johnson, S.J. Goldberg, and J.B. Ulreich. 1990. Cardiac teratogenesis of trichloroethylene in a mammalian model. J. Am. Coll. Cardiol. 16(5):1304-1309. Dawson, B.V., P.D. Johnson, S.J. Goldberg, and J.B. Ulreich. 1993. Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water. J. Am. Coll. Cardiol. 21(6):1466-1472. Deane, M., S.H. Swan, J.A. Harris, D.M. Epstein, and R.R. Neutra. 1989. Adverse pregnancy outcomes in relation to water contamination, Santa Clara County, California, 1980-1981. Am. J. Epidemiol. 129(5):894-904. DeAngelo, A.B., F.B. Daniel, L. McMillan, P. Wernsing, and R.E. Savage, Jr. 1989. Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. Toxicol. Appl. Pharmacol. 101(2):285-298. DeAngelo, A.B., F.B. Daniel, J.A. Stober, and G.R. Olson. 1991. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16(2):337-347. DeAngelo, A.B., F.B. Daniel, B.M. Most, and G.R. Olson. 1996. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114(3):207-221. DeAngelo, A.B., F.B. Daniel, B.M. Most, and G.R. Olson. 1997. Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. J. Toxicol. Environ. Health 52(5):425-445. DeAngelo, A.B., M.H. George, and D.E. House. 1999. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: Dose-response determination and modes of action. J. Toxicol. Environ. Health 58(8):485-507. de Duve, C. 1969. The peroxisome: A new cytoplasmic organelle. Proc. R Soc. Lond. B Biol. Sci. 173(30):71-83. DeGroot, M.H. 1989. Probability and Statiscs, 2nd Ed. Reading, MA: Addison-Wesley. De Jong, P.E., and B.M. Brenner. 2004. From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria. Kidney Int. 66(6):2109-2118. Dekant, W. 1986. Metabolic conversion of tri- and tetrachloroethylene: Formation and deactivation of genotoxic intermediates. Dev. Toxicol. Environ. Sci. 12:211-221. Dekant, W., M. Metzler, and D. Henschler. 1984. Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem. Pharmacol. 33(13):2021-2027. Dekant, W., A. Schulz, M. Metzler, and D. Henschler. 1986a. Absorption, elimination and metabolism of trichloroethylene: A quantitative comparison between rats and mice. Xenobiotica 16(2):143-152. Dekant, W., M. Metzler, and D. Henschler. 1986b. Identification of S-1,2,2-trichlorovinyl-Nacetylcysteine as a urinary metabolite of tetrachloroethylene: Bioactivation through glu-

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Sausen, P.J., R.J. Duescher, and A.A. Elfarra. 1993. Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol. Pharmacol. 43(3):388-396. Scheff, P.A., and R.A. Wadden. 1993. Receptor modeling of volatile organic compounds: 1. Emission inventory and validation. Environ. Sci. Technol. 27(4):617-625. Schlehofer, B., C. Heuer, M. Blettner, D. Niehoff, and J. Wahrendorf. 1995. Occupation, smoking and demographic factors, and renal cell carcinoma in Germany. Int. J. Epidemiol. 24(1):51-57. Schultz, I.R., J.L. Merdink, A. Gonzalez-Leon, and R.J. Bull. 2002. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: Dose-response relationships and age as a modifying factor. Toxicology 173(3):229-247. Schuz, J., U. Kaletsch, R. Meinert, P. Kaatsch, and J. Michaelis. 2000. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: Results from pooled analyses of German population-based case-control studies. Cancer Epidemiol. Biomarkers Prev. 9(8):835-838. Schwetz, B.A., K.J. Leong, and P.J. Gehring. 1975. The effect of maternally inhaled trichloroethylene, perchloroethylene, methyl chloroform, and methylene chloride on embryonal and fetal development in mice and rats. Toxicol. Appl. Pharmacol. 32(1):84-96. Scott, C.S., and V.J. Cogliano. 2000. Introduction: trichloroethylene health risks—state of the science. Environ. Health Perspect. 108(Suppl. 2):159-160. Scott, J.E., P.G. Forkert, M. Oulton, M.G. Rasmussen, S. Temple, M.O. Frazer, and S. Whitefield. 1988. Pulmonary toxicity of trichloroethylene: Induction of changes in surfactant phosphor lipids and phospholipase AZ activity in the murine lung. Exp. Mol. Pathol. 49(1):141-150. SEER (Surveillance, Epidemiology, and End Results Program). 2005. SEER*Stat Databases: Incidence - SEER 13 Regs Public-Use, Nov. 2004 Sub. for Expanded Races (1992-2002) and Incidence - SEER 13 Regs excluding AK Public-Use, Nov. 2004 Sub. for Hispanics (1992-2002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. April 2005 [online]. Available: http://www.seer.cancer.gov [accessed June 21, 2006]. Seidler, A., E. Raum, B. Arabin, W. Hellenbrand, U. Walter, and F.W. Schwartz. 1999. Maternal occupational exposure to chemical substances and the risk of infants small-for-gestationalage. Am. J. Ind. Med. 36(1):213-222. Seiji, K., O. Inoue, C. Jin, Y.T. Liu, S.X. Cai, M. Ohashi, T. Watanabe, H. Nakatsuka, T. Kawai, and M. Ikeda. 1989. Dose excretion relationship in tetrachloroethylene exposed-workers and the effect of tetrachloroethylene co-exposure on trichloroethylene metabolism. Am. J. Ind. Med. 16(6):675-684. Seldén, A., and G. Ahlborg. 1991. Mortality and cancer morbidity after exposure to military aircraft fuel. Aviat. Space Environ. Med. 62(8):789-794. Self, S.G., and R.H. Mauritsen. 1988. Power/sample size calculations for generalized linear models. Biometrics 44(1):79-86. Self, S.G., R.H. Mauritsen, and J. Ohara. 1992. Power calculations for likelihood ratio tests in generalized linear models. Biometrics 48(1):31-39. Sellers , E.M., and J. Koch-Weser. 1970. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate. N. Engl. J. Med. 283(16):827-831. Sellers, E.M., M. Lang, J. Koch-Weser, E. LeBlanc, and H. Kalant. 1972. Interaction of chloral hydrate and ethanol in man. I. Metabolism. Clin. Pharmacol. Ther. 13(1):37-49. Sellers, E.M., M. Lang-Sellers, and J. Koch-Weser. 1978. Comparative metabolism of chloral hydrate and trichlofos. J. Clin. Pharmacol. 18(1):457-461. Sexton, K., J.L. Adgate, G. Ramachandran, G.C. Pratt, S.J. Mongin, T.H. Stock, and M.T.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Morandi. 2004. Comparison of personal, indoor, and outdoor exposures to hazardous air pollutants in three urban communities. Environ. Sci. Technol. 38(2):423-430. Sexton, K., J.L. Adgate, T.R. Church, D.L. Ashley, L.L. Needham, G. Ramachandran, A.L. Fredrickson, and A.D. Ryan. 2005. Children‘s exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ. Health Perspect. 113(3):342-349. Shah, J.J., and H.B. Singh. 1988. Distribution of volatile organic chemicals in outdoor and indoor air. Environ. Sci. Technol. 22(12):1381-1388. Shapiro, S. 1994. Meta-analysis/Shmeta-analysis. Am. J. Epidemiol. 140(9):771-778. Sharpe, C.R., J.E. Rochon, J.M. Adam, and S. Suissa. 1989. Case-control study of hydrocarbon exposures in patients with renal cell carcinoma. CMAJ 140(11):1309-1318. Shaw, G.M., L.H. Malcoe, and E. Katz. 1992. Maternal workplace exposures to organic solvents and congenital cardiac anomalies. J. Occup. Med. Toxicol. 1:371-376. Sheffels, P., J.L. Schroeder, T.G. Altuntas, H.D. Liggitt, and E.D. Kharasch. 2004. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (“compound A”) in rats. Chem. Res. Toxicol. 17(9):1177-1189. Sherman, C.D., and C.J. Portier. 1997. The two-stage model of carcinogenesis: Overcoming the nonidentifiability dilemma. Risk Anal. 17(3):367-374. Shiao, Y.H. 2004. VHL alterations and renal tumorigenesis. Presentation at EPA Symposium on New Scientific Research Related to the Health Effects of TCE, February 26-27, 2004, Washington, DC. Shiao, Y.H., B.A. Diwan, A.O. Perantoni, R.J. Calvert, B. Zbar, M.I. Lerman, and J.M. Rice. 1997. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol. Carcinog. 19(4):230-235. Shiao, Y.H., J.M. Rice, L.M. Anderson, B.A. Diwan, and G.C. Hard. 1998. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J. Natl. Cancer Inst. 90(22):1720-1723. Shih, C.L., H.H. Chen, and T.H. Chiu. 2001. Acute exposure to trichloroethylene differentially alters the susceptibility to chemoconvulsants in mice. Toxicology 162(1):35-42. Shimada, T., H. Yamazaki, M. Mimura, Y. Inui, and F.P. Guengerich. 1994. Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270(1):414-423. Shindell, S., and S. Ulrich. 1985. A cohort study of employees of a manufacturing plant using trichloroethylene. J. Occup. Med. 27(8):577-579. Shu, X.O., P. Stewart, W.Q. Wen, D. Han, J.D. Potter, J.D. Buckley, E. Heineman, and L.L. Robison. 1999. Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol. Biomarkers Prev. 8(9):783-791. Shultz, J., and H. Weiner. 1979. Alteration of the enzymology of chloral hydrate reduction in the presence of ethanol. Biochem. Pharmacol. 28(23):3379-3384. Sieber, W.K., Jr., D.S. Sundin, T.M. Frazier, and C.F. Robinson. 1991. Development, use, and availability of a job exposure matrix based on national occupational hazard survey data. Am. J. Ind. Med. 20(2):163-174. Siemiatycki, J. 1991. Risk Factors for Cancer in the Workplace. Boca Raton, FL: CRC Press. Siemiatycki, J., N.E. Day, J. Fabry, and J.A. Cooper. 1981. Discovering carcinogens in the occupational environment: A novel epidemiologic approach. J. Natl. Cancer Inst. 66(2):217-225. Siemiatycki, J., S. Wacholder, L. Richardson, R. Dewar, and M. Gerin. 1987. Discovering car-

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues cinogens in the occupational environment. Methods of data collection and analysis of a large case-referent monitoring system. Scand. J. Work Environ. Health 13(6):486-492. Simmons, J.E., W.K. Boyes, P.J. Bushnell, J.H. Raymer, T. Limsakun, A. McDonald, Y.M. Sey, and M.V. Evans. 2002. A physiologically based pharmacokinetic model for trichloroethylene in the male Long-Evans rat. Toxicol. Sci. 69(1):3-15. Sinks, T., B. Lushniak, B.J. Haussler, J. Sniezek, J.F. Deng, P. Roper, P. Dill, and R. Coates. 1992. Renal cell cancer among paperboard printing workers. Epidemiology 3(6):483-489. Smith, M., D.A. Hopkinson, and H. Harris. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann. Hum. Genet. 34(3):251-271. Smith, M.K., J.L. Randall, E.J. Read, and J.A. Stober. 1989. Teratogenic activity of trichloroacetic acid in the rat. Teratology 40(5):445-451. Smith, M.K., J.L. Randall, E.J. Read, and J.A. Stober. 1992. Developmental toxicity of dichloroacetate in the rat. Teratology 46(3):217-223. Smith, T.J. 2002. Issues in exposure and dose assessment for epidemiology and risk assessment. Hum. Ecol. Risk Assess. 8(2):1267-1293. Smith, T.J., P.A. Stewart, and R.F. Herrick. 1995. Retrospective exposure assessment. Pp. 308-323 in Occupational Hygiene, 2nd Ed., J.M. Harrington and K. Gardiner, eds. London: Blackwell Science. Snow, J. 1856. Cholera and the water supply in the south districts of London, in 1854. J. Public Health San. Rev. 2(Oct.):239-257. Solus, J.F., B.J. Arietta, J.R. Harris, D.P. Sexton, J.Q. Steward, C. McMunn, P. Ihrie, J.M. Mehall, T.L. Edwards, and E.P. Dawson. 2004. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 5(7):895-931. Soni, M.G., R.S. Mangipudy, M.M. Mumtaz, and H.M. Mehendale. 1998. Tissue repair response as a function of dose during trichloroethylene hepatotoxicity. Toxicol. Sci. 42(2):158-165. Soni, M.G., S.K. Ramaiah, M.M. Mumtaz, H. Clewell, and H.M. Mehendale. 1999. Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul. Toxicol. Pharmacol. 29(2 Pt 1):165-174. Sonnenfeld, N., I. Hertz-Picciotto, and W.E. Kaye. 2001. Tetrachloroethylene in drinking water and birth outcomes at the US Marine Corps Base at Camp Lejeune, North Carolina. Am. J. Epidemiol. 154(1):902-908. Sorokin, S.P. 1970. The cells of the lung. Pp. 3-43 in Morphology of the Experimental Respiratory Carcinogenesis, P. Nettesheim, M.G. Hanna, and J.W. Deatherage, eds. AEC Symposium Series 21. Oak Ridge TN: U.S. Energy Commission. Soucek, T., R.S. Yeung, and M. Hengstschlager. 1998. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95(26):15653-15658. Spirtas, R., P.A. Stewart, J.S. Lee, D.E. Marano, C.D. Forbes, D.J. Grauman, H.M. Pettigrew, A. Blair, R.N. Hoover, and J.L. Cohen. 1991. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br. J. Ind. Med. 48(8):515-530. Stauber, A.J., and R.J. Bull. 1997. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). Toxicol. Appl. Pharmacol. 144(2):235-246. Stauber, A.J., R.J. Bull, and B.D. Thrall. 1998. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol. Appl. Pharmacol. 150(2):287-294. Stayner, L., K. Steenland, M. Dosemeci, and I. Hartz-Picciotto. 2003. Attenuation of exposureresponse curves in occupational cohort studies at high exposures. Scand. J. Work Environ. Health 29(4):317-324.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Steenland, K., J. Deddens, A. Salvan, and L. Stayner. 1996. Negative bias in exposure-response trends in occupational studies: Modeling the healthy workers survivor effect. Am. J. Epidemiol. 143(2):202-210. Steenland, K., J.A. Deddens, and S. Zhao. 2000. Biases in estimating the effect of cumulative exposure in log-linear models when estimated exposure levels are assigned. Scand. J. Work Environ. Health 26(1):37-43. Steinberg, A.D. 1993. Should chloral hydrate be banned? Pediatrics 92(3):442-446. Stemhagen, A., J. Slade, R. Altman, and J. Bill. 1983. Occupational risk factors and liver cancer. A retrospective case-control study of primary liver cancer in New Jersey. Am. J. Epidemiol. 117(4):443-454. Stenner, R.D., J.L. Merdink, D.K. Stevens, D.L. Springer, and R.J. Bull. 1997. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of tricholoacetic acid. Metabolites of trichloroethylene. Drug Metab.Dispos. 25(5):529-535. Stenner, R.D., J.L. Merdink, J.W. Fisher, and R.J. Bull. 1998. Physciologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. Risk Anal. 18(3):261-269. Steup, D.R., D. Wiersma, D.A. McMillan, and I.G. Sipes. 1991. Pretreatment with drinking water solutions containing trichloroethylene or chloroform enhances the hepatotoxicity of carbon tetrachloride in Fischer 344 rats. Fundam. Appl. Toxicol. 16(4):798-809. Steup, D.R., P. Hall, D.A. McMillan, and I.G. Sipes. 1993. Time course of hepatic injury and recovery following coadministration of carbon tetrachloride and trichloroethylene in Fischer-344 rats. Toxicol. Pathol. 21(3):327-334. Stevens, J.L. 1985. Isolation and characterization of a rat liver enzyme with both cysteine conjugate beta-lyase and kynureninase activity. J. Biol. Chem. 260(13):7945-7950. Stevens, J.L., J.D. Robbins, and R.A. Byrd. 1986. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J. Biol. Chem. 261(33):15529-15537. Stewart, B.W., S.M. Le Mesurier, and A.W. Lykke. 1979. Correlation of the biochemical and morphological changes induced by chemical injury in the lung. Chem.Biol. Interact. 26(3):321-338. Stewart, P., and M. Dosemeci. 2005. Exposure Estimation in Occupational Epidemiology Studies. Presentation at the Third Meeting on Assessing Human Health Risks of Trichloroethylene, June 9, 2005, Irvine, CA. Stewart, P.A., J.S. Lee, D.E. Marano, R. Spirtas, C.D. Forbes, and A. Blair. 1991. Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. Br. J. Ind. Med. 48(8):531-537. Stewart, P.A., W.F. Stewart, J. Siemiatycki, F.F. Heineman, and M. Dosemeci. 1998. Questionnaires for collecting detailed occupational information for community-based case control studies. Am. Ind. Hyg. Assoc. J. 59(1):39-44. Stewart, R.D., H.C. Dodd, H.H. Gay, and D.S. Erley. 1970. Experimental human exposure to trichloroethylene. Arch. Environ. Health 20(1):64-71. Stewart, R.D., C.L. Hake, and J.E. Peterson. 1974. Degreasers’ flush: Dermal response to trichloroethylene and ethanol. Arch. Environ. Health 29(1):1-5. Stewart, W.F., and P.A. Stewart. 1994. Occupational case-control studies: II. Recommendations for exposure assessment. Am. J. Ind. Med. 26(3):313-326. Stopps, G.J., and M. McLaughlin. 1967. Psychophysiological testing of human subjects exposed to solvent vapors. Am. Ind. Hyg. Assoc. J. 28(1):43-50. Strange, R.C., C.G. Faulder, B.A. Davis, R. Hume, J.A. Brown, W. Cotton, and D.A. Hopkinson. 1984. The human glutathione S-transferases: Studies on the tissue distribution

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues and genetic variation of the GST1, GST2 and GST3 isozymes. Ann. Hum. Genet. 48(Pt 1):11-20. Strange, R.C., A.F. Howie, R. Hume, B. Matharoo, J. Bell, C. Hiley, P. Jones, and G.J. Beckett. 1989. The development expression of alpha-, mu- and pi-class glutathione S-transferases in human liver. Biochim. Biophys. Acta 993(2-3):186-190. Strange, R.C., B. Matharoo, G.C. Faulder, P. Jones, W. Cotton, J.B. Elder, and M. Deakin. 1991. The human glutathione S-transferases: A case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12(1):25-28. Swaen, G.M. 1995. Increased incidence of renal cell tumours in a cohort of cardboard workers exposed to trichloroethylene [letter]. Arch. Toxicol. 70(2):127-128, 131-133. Swan, S.H., G. Shaw, J.A. Harris, and R.R. Neutra. 1989. Congenital cardiac anomalies in relation to water contamination, Santa Clara County, California, 1981-1983. Am. J. Epidemiol. 129(5):885-893. Sweet, C.W., and S.J. Vermette. 1992. Toxic volatile organic compounds in urban air in Illinois. Environ. Sci. Technol. 26(1):165-173. Tao, L., K. Li, P.M. Kramer, and M.A. Pereira. 1996. Loss of heterozygosity on chromosome 6 in dichloroacetic acid and trichloroacetic acid-induced liver tumors in female B6C3F1 mice. Cancer Lett. 108(2):257-261. Tao, L., R. Ge, M. Xie, P.M. Kramer, and M.A. Pereira. 1999. Effect of trichloroethylene on DNA methylation and expression of early-intermediate protooncogenes in the liver of B6C3F1 mice. J. Biochem. Mol. Toxicol. 13(5):231-237. Tao, L., S. Yang, M. Xie, P.M. Kramer, and M.A. Pereira. 2000a. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett. 158(2):185-193. Tao, L., S. Yang, M. Xie, P.M. Kramer, and M.A. Pereira. 2000b. Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun and c-Myc protooncogenes in mouse liver: Prevention by methionine. Toxicol. Sci. 54(2):399-407. Tao, L., W. Wang, P.M. Kramer, and M.A. Pereira. 2004a. Effect of dibromoacetic acid on DNA methylation, glycogen accumulation, and peroxisome proliferation in mouse and rat liver. Toxicol. Sci. 82(1):62-69. Tao, L., Y. Li, P.M. Kramer, W. Wang, and M.A. Perieira. 2004b. Hypomethylation of DNA and the insulin-like growth factor-II gene in dichloroacetic and trichloroacetic acid-promoted liver mouse tumors. Toxicology 196(1-2):127-136. Tao, L., W. Wang, L. Li, P.M. Kramer, and M.A. Pereira. 2005. DNA hypomethylation induced by drinking water disinfection by-products in mouse and rat kidney. Toxicol. Sci. 87(2):344-352. Taskinen, H., A. Anttila, M.L. Lindbohm, M. Sallmen, and K. Hemminki. 1989. Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents. Scand. J. Work Environ. Health 15(5):345-352. Templin, M.V., J.C. Parker, and R.J. Bull. 1993. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 123(1):1-8. Templin, M.V., D.K. Stevens, R.D. Stenner, P.L. Bonate, D. Tuman, and R.J. Bull. 1995. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J. Toxicol. Environ. Health 44(4):435-447. Thaete, L.G., and A.M. Malkinson. 1991. Cells of origin of primary pulmonary neoplasms in mice: Morphologic and histochemical studies. Exp. Lung Res. 17(2):219-228. Thai, S.F., J.W. Allen, A.B. DeAngelo, M.H. George, and J.C. Fuscoe. 2003. Altered gene expression in mouse liver after dichloroacetic acid exposure. Mutat. Res. 543(2):167-180.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Thiele, D.L., E.H. Eigenbrodt, and A.J. Ware. 1982. Cirrhosis after repeated trichloroethylene and 1,1,1-trichloroethane exposure. Gastroenterology 83(4):926-929. Thomas, D.C. 1987. Use of computer simulation to explore analytical issues in nested case-control studies of cancer involving extended exposures: Methods and preliminary findings. J. Chronic Dis. 40(Suppl. 2):201S-208S. Thomasson, H.R., H.J. Edenberg, D.W. Crabb, X.L. Mai, R.E., Jerome, T.K. Li, S.P. Wang, Y.T. Lin, R.B. Lu, and S.J. Yin. 1991. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48(4):677-681. Thomasson, H.R., J.D. Beard, and T.K. Li. 1995. ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcohol Clin. Exp. Res. 19(6):1494-1499. Thrall, K.D., and T.S. Poet. 2000. Determination of biokinetic interactions in chemical mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A 59(8):653-670. Tielemans, E., D. Heederik, A. Burdorf, R. Vermeulen, H. Veulemans, H. Kromhout, and K. Hartog. 1999. Assessment of occupational exposures in a general population: Comparison of different methods. Occup. Environ. Med. 56(3):145-151. Tikkanen, J., and O.P. Heinonen. 1988. Cardiovascular malformations and organic solvent exposure during pregnancy in Finland. Am. J. Ind. Med. 14(1):1-8. ‘t Mannetje, A., K. Steenland, M. Attfield, P. Boffetta, H. Checkoway, N. DeKlerk, and R.S. Koskela. 2002. Exposure-response analysis and risk assessment for silica and silicosis mortality in a pooled analysis of six cohorts. Occup. Environ. Med. 59(11):723-728. Tola, S., R. Vilhunen, E. Jarvinen, and M.L. Korkala. 1980. A cohort study on workers exposed to trichloroethylene. J. Occup. Med. 22(11):737-740. Tong, Z., P.G. Board, and M.W. Anders. 1998. Glutathione transferase zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331(Pt. 2):371-374. Triebig, G., S. Lehrl, W. Kinzel, H. Erzigkeit, J.V. Galster, and K.H. Schaller. 1977. Psychopathometrical results of follow-up studies of trichloroethylene-exposed persons [in German]. Zentralbl. Bakteriol. 164(4):314-377. Turkall, R.M., G.A. Skowronski, D.H. Suh, and M.S. Abdel-Rahman. 2003. Effect of a chemical mixture on dermal penetration of arsenic and nickel in male pig in vitro. J. Toxicol. Environ. Health 66(7):647-655. USAF-EPA (U.S. Air Force-U.S. Environmental Protection Agency). 2004a. Development of a Physiologically-Based Pharmacokinetic Model of Trichloroethylene and Its Metabolites for Use in Risk Assessment. Prepared for U.S. Air Force by U.S. Air Force-U.S. Environmental Protection Agency Trichloroethylene Physiogically-Based Pharmacokinetic Model Workgroup. October 14, 2004 [online]. Available: http://www.tera.org/vera/TCE/TCE%20PBPK%20harmonization%20document.pdf [accessed April 3, 2006]. USAF-EPA (U.S. Air Force-U.S. Environmental Protection Agency Trichloroethylene Physiogically-Based Pharmacokinetic Model Workgroup). 2004b. Report of the Peer Consultation of Harmonized PBPK Model for Trichloroethylene. September 29, 2004 [online]. Available: http://www.tera.org/vera/TCE/TCE%20PBPK%20Peer%20Consultation%20Meeting%20Report%20final.pdf [accessed April 3, 2006]. Vaidya, V.S., K. Shankar, E.A. Lock, T.J. Bucci, and H.M. Mehendale. 2003a. Renal injury and repair following S-1, 2 dichlorovinyl-L-cysteine administration to mice. Toxicol. Appl. Pharmacol. 188(2):110-121. Vaidya, V.S., K. Shankar, E.A. Lock, T.J. Bucci, and H.M. Mehendale. 2003b. Role of tissue repair in protection from S-(1, 2 dichlorovinyl)-L-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol. Sci. 74(1):215-227. Vaidya,V.S., K. Shankar, E.A. Lock, D. Dixon, H.M. Mehendale. 2003c.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Molecular mechanisms of renal tissue repair in survival from acute renal tubule necrosis: Role of ERK1/2 pathway. Toxicol. Pathol. 31(6):604-618. Vamvakas, S., T. Brüning, B. Thomasson, M. Lammert, A. Baumuller, F. Bolt, W. Dekant, G. Birner, D. Henschler, and K. Ulm. 1998. Renal cell cancer correlated with occupational exposure to trichloroethene. J. Cancer Res. Clin. Oncol. 124(7):374-382. Vanden Heuvel, J.P. 1999a. Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J. Nutr. 129(2S Suppl):575S-580S. Vanden Heuvel, J.P. 1999b. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicol. Sci. 47(1):1-8. Vandervort, R., and P.L. Polakoff. 1973. Health Hazard Evaluation Report HHE-72-84-31, Dunham-Bush, Inc., West Hartford, Connecticut. Hazard Evaluation Services Branch, National Institute for Occupational Safety and Health, Cincinnati, OH. Van Duuren, B.L., B.M. Goldschmidt, G. Loewengart, A.C. Smith, S. Melchionne, I. Seldman, and D. Roth. 1979. Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. J. Natl. Cancer Inst. 63(6):1433-1439. van Lieshout, E.M., M.F. Knapen, W.P. Lange, E.A. Steegers, and W.H. Peters. 1998. Localization of glutathione S-transferases alpha and pi in human embryonic tissues at 8 weeks gestational age. Hum. Reprod. 13(5):1380-1386. van Poppel, G., N. de Vogel, P.J. van Balderen, and F.J. Kok. 1992. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis 13(2):303-305. Vasiliou, V., A. Pappa, and T. Estey. 2004. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab. Rev. 36(2):279-299. Veeramachaneni, D.N.R., J.S. Palmer, and R.P. Amann. 2001. Long-term effects on male reproduction of early exposure to common chemical contaminants in drinking water. Hum. Reprod. 16(5):979-987. Verhave, J.C., R.T. Ganesvoorth, H.L. Hillege, S.J. Bakker, D. De Zeeuw, and P.E. De Jong. 2004. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int. 92(Supl.):S18-S21. Verma, Y., and S.V. Rana. 2003. Gender differences in the metabolism of benzene, toluene and trichloroethylene in rat with special reference to certain biochemical parameters. J. Environ. Biol. 24(2):135-140. Viljoen, D.L., L.G. Carr, T.M. Foroud, L. Brooke, M. Ramsay, and T.K. Li. 2001. Alcohol dehydrogenase-2*2 allele is associated with decreased prevalence of fetal alcohol syndrome in the mixed-ancestry population of the Western Cape Province, South Africa. Alcohol Clin. Exp. Res. 25(12):1719-1722. Volkel, W., and W. Dekant. 1998. Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate beta-lyase-mediated cleavage of the trichloroethene metabolite S-(1,2-Dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem. Res. Toxicol. 11(9):1082-1088. Volkel, W., M. Friedewald, E. Lederer, A. Pahler, J. Parker, and W. Dekant. 1998. Biotransformation of perchloroethene: Dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L- cysteine in rats and humans after inhalation. Toxicol. Appl. Pharmacol. 153(1):20-27. Von Tungeln, L.S., P. Yi, T.J. Bucci, V.M. Samokyszyn, M.W. Chou, F.F. Kadlubar, and P.P. Fu. 2002. Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse. Cancer Lett. 185(1):13-19. Wacholder, S., J.K. McLaughlin, D.T. Silverman, and J.S. Mandel. 1992a. Selection of controls in case-control studies. I. Principles. Am. J. Epidemiol. 135(9):1019-1028.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Wacholder, S., D.T. Silverman, J.K. McLaughlin, and J.S. Mandel. 1992b. Selection of controls in case-control studies. III. Design options. Am. J. Epidemiol. 135(9):1042-1050. Wakefield, J.C., and N. Rahman. 2000. The combination of population pharmacokinetic studies. Biometrics 56(1):263-270. Walgren, J.E., D.T. Kurtz, and J.M. McMillan. 2000a. The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes. Cell Biol. Toxicol. 16(4):257-273. Walgren, J.E., D.T. Kurtz, and J.M. McMillan. 2000b. Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 108(1-2):116-132. Walgren, J.L., D.J. Jollow, and J.M. McMillan. 2004. Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology 197(3):189-197. Walker, C. 1998. Molecular genetics of renal carcinogenesis. Toxicol. Pathol. 26(1):113-120. Walker, C., Y.T. Ahn, J. Everitt, and X. Yuan. 1996. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Mol. Carcinog. 15(2):154-161. Wallace, L.A., E.D. Pellizzari, T.D. Hartwell, C. Sparacino, R. Whitmore, L. Sheldon, H. Zelon, and R. Perritt. 1987. The TEAM (Total Exposure Assessment Methodology) Study: Personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ. Res. 43(2):290-307. Waller, P.A., D. Clauw, T. Cupps, J.S. Metcalf, R.M. Silver, and E.C. Leroy. 1994. Fasciitis (not scleroderma) following prolonged exposure to an organic solvent (trichloroethylene). J. Rheumatol. 21(8):1567-1570. Wang, F.I., M.L. Kuo, C.T. Shun, Y.C. Ma, J.D. Wang, and T.H. Ueng. 2002. Chronic toxicity of a mixture of chlorinated alkanes and alkenes in ICR mice. J. Toxicol. Environ. Health A 65(3-4):279-291. Wang, G.F., and N.H. Stacey. 1990. Elevation of individual serum bile acids on exposure to trichloroethylene or alpha-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 105(2): 209-215. Wang, J.L., W.L. Chen, S.Y. Tsai, P.Y. Sung, and R.N. Huang. 2001. An in vitro model for evaluation of vaporous toxicity of trichloroethylene and tetrachloroethylene to CHO-K1 cells. Chem. Biol. Interact. 137(2):139-154. Wang, R.S., T. Nakajima, and T. Honma. 1999. Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 132(1):9-18. Wang, X., and A.A. Abdel-Rahman. 2005. Effect of chronic ethanol administration on hepatic eNOS activity and its association with caveolin-1 and calmodulin in female rats. Am. J. Physiol. Gastrointest. Liver Physiol. 289(3):G579-G585. Warren, K.R., and T.K. Li. 2005. Genetic polymorphisms: Impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res. A Clin. Mol. Teratol 73(4):195-203. Wartenberg, D., D. Reyner, and C.S. Scott. 2000. Trichloroethylene and cancer: Epidemiologic evidence. Environ. Health Perspect. 108(Suppl. 2):161-176. Waseem, M., M. Ali, S. Dogra, K.K. Dutta, and J.L. Kaw. 2001. Toxicity of trichloroethylene following inhalation and drinking contaminated water. J. Appl. Toxicol. 21(6):441-444. Watanabe, M., T. Takano, and K. Nakamura. 1998. Effect of ethanol on the metabolism of trichloroethylene in the perfused rat liver. J. Toxicol. Environ. Health A 55(4):297-305. Watanabe, S., and T. Fukui. 2000. Suppressive effect of curcumin on trichloroethylene-induced oxidative stress. J. Nutr. Sci. Vitaminol. (Tokyo) 46(5):230-234. Waxman, D.J. 1999. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369(1):11-23. Weiss, B., and D.A. Cory-Slechta. 2001. Assessment of behavioral toxicity. Pp. 1451-1528 in Principles and Methods of Toxicology, 4th Ed., A.W. Hayes, ed. Philadelphia, PA: Taylor & Francis.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues Werner, M., G. Birner, and W. Dekant. 1995a. The role of cytochrome P4503A1/2 in the sexspecific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)- L-cysteine in rats. Drug Metab. Dispos. 23(8):861-868. Werner, M., Z.Y.Guo, G. Birner, W. Dekant, and F.P. Guengerich. 1995b. The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem. Res. Toxicol. 8(7):917-923. Werner, M., G. Birner, and W. Dekant. 1996. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: A bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Chem. Res. Toxicol. 9(1):41-49. West, D.P., S. Worobec, and L.M. Solomon. 1981. Pharmacology and toxicology of infant skin. J. Invest. Dermatol. 76(3):147-150. Wheeler, C.W., S.A. Wrighton, and T.M. Guenthner. 1992. Detection of human cytochrome P450 that are immunochemically related to the cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44(1):183-186. White, K.L., D.W. David, L.F. Butterworth, and P.C. Klykken. 2000. Assessment of autoimmunity-inducing potential using the brown Norway rat challenge model. Toxicol. Lett. 112-113:443-451. White, R.F., R.G. Feldman, I.I. Eviator, J.F. Jabre, and C.A. Niles. 1997. Hazardous waste and neurobehavioral effects: A developmental perspective. Environ. Res. 73(1-2):113-124. Wilcosky, T.C., H. Checkoway, E.G. Marshall, and H.A. Tyroler. 1984. Cancer mortality and solvent exposures in the rubber industry. Am. Ind. Hyg. Assoc. J. 45(12):809-811. Willey, J.C., E. Coy, C. Brolly, M.J. Uteli, M.W. Frampton, J. Hammersley, W.G. Thilly, D. Olson, and K. Cairns. 1996. Xenobiotic metabolism enzyme gene expression in bronchial and alveolar macrophage cells. Am. J. Resp. Cell Mol. Biol. 14(3):262-271. Windham, G.C., D. Shusterman, S.H. Swan, L. Fenster, and B. Eskenazi. 1991. Exposure to organic solvents and adverse pregnancy outcome. Am. J. Ind. Med. 20(2):241-259. Wong, O. and P. Decoufle. 1982. Methodological issues involving the standardized mortality ratio and proportionate mortality ratio in occupational studies. J. Occup. Med. 24(4):299-304. Wong, O., and R. Morgan. 1990. Historical Prospective Mortality Study of Hughes Aircraft Employees at Air Force Plant #44. Final Report. 4700-042-001. Alameda, CA: ENSR Health Sciences. Wrensch, M., S. Swan, J. Lipscomb, D. Epstein, L. Fenster, K. Claxton, P.J. Murphy, D. Shusterman, and R. Neutra. 1990a. Pregnancy outcomes in women potentially exposed to solvent-contaminated drinking water in San Jose, California. Am. J. Epidemiol. 131(2):283-300. Wrensch, M., S. Swan, P.J. Murphy, J. Lipscomb, K. Claxton, D. Epstein, and R. Neutra. 1990b. Hydrogeologic assessment of exposure to solvent-contaminated drinking water: Pregnancy outcomes in relation to exposure. Arch. Environ. Health 45(4):210-216. Wright, P.F., W.D. Thomas, and N.H. Stacey. 1991. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicology 70(2):231-242. Wrighton, S.A., and J.C. Stevens. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22(1):1-21. Wu, C., and J. Schaum. 2000. Exposure assessment of trichloroethylene. Environ Health Perspect 108(suppl. 2):359-358. Xu., H., N. Tanphaichitr, P.G. Forkert, A. Anupriwan, W. Weerachatyanukul, R. Vincent, A. Leader, and M.G. Wade. 2004. Exposure to trichloroethylene and its metabolites causes impairment of sperm fertilizing ability in mice. Toxicol. Sci. 82(2):590-597. Yang, M., B.F. Coles, R. Delongchamp, N.P. Lang, and F.F. Kadlubar. 2002. Effects of the

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue. Lung Cancer 38(1):15-21. Yang, S.P., and G.M. Raner. 2005. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol. Appl. Pharmacol. 202(2):140-150. Yauck, J.S., M.E. Malloy, K. Blair, P.M. Simpson, and D.G. McCarver. 2004. Proximity of residence to trichloroethylene-emitting sites and increased risk of offspring congenital heart defects among older women. Birth Defects Res. A. Clin. Mol. Teratol 70(10):808-814. Yeldandi, A.V., M.S. Rao, and J.K. Reddy. 2000. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448(2):159-177. Yokoyama, A., T. Muramatsu, T. Omori, T. Yokoyama, S. Matsushita, S. Higuchi, K. Maruyama, and H. Ishii. 2001. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22(3):433-439. Youssef, J.A, and M.Z. Badr. 2002. Enhanced hepatocarcinogenicity due to agonists of peroxisome proliferator-activated receptors in senescent rats: Role of peroxisome proliferation, cell proliferation, and apoptosis. Sci. World J. 2:1491-1500. Youssef, J.A., and M.Z. Badr. 2005. Aging and enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists. Ageing Res. Rev. 4(1):103-118. Yu, S., S. Rao, and J.K. Reddy. 2003. Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr. Mol. Med. 3(6):561-572. Zandi-Nejad, K., A.A. Eddy, R.J. Glassock, and B.M. Brenner. 2004. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int. 92(Supl.):S76-S89. Zenick, H., K. Blackburn, E. Hope, N. Richdale, and M.K. Smith. 1984. Effects of trichloroethylene exposure on male reproductive function in rats. Toxicology 31(3-4):237-250. Zhang, G.H., and J.L. Stevens. 1989. Transport and activation of S-(1.2-dichlorovinyl)-Lcysteine and N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine in rat kidney proximal tubules. Toxicol. Appl. Pharmacol. 100(1):51-61. Zhao, C.Y., and L.L. Jiang. 2003. Peroxisome proliferator-activated receptor in liver diseases [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 11(6):382-384. Zhao, Y., A. Krishnadasan, N. Kennedy, H. Morganstern, and B. Ritz. 2005. Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers. Am. J. Ind. Med. 48(4):249-258. Zhu, J., R. Newhook, L. Marro, and C.C. Chan. 2005. Selected volatile organic compounds in residential air in the city of Ottawa, Canada. Environ. Sci. Technol. 39(11):3964-3971. Zielinska, B., E. Fujita, J. Sagebiel, G. Harshfield, E. Uberna, T. Hayes, and F. Keene. 1998. Arizona Hazardous Air Pollutants Monitoring Program. J.Air Waste Manage. Assoc. 48(11):1038-1050.

OCR for page 329
Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues This page intentionally left blank.